LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

European Biotech Week 2021: EuropaBio invites national biotech communities to celebrate science and innovation

14/06/2021
PRESS RELEASE

European Biotech Week 2021: EuropaBio invites national biotech communities to celebrate science and innovation

Brussels, Belgium – 15 June 2021 – EuropaBio officially launches the campaign of the European Biotech Week 2021 and invites the biotech community to celebrate science and innovation on European and national levels.

The European Biotech Week, which takes place 27 September -3 October this year, is a momentous occasion to better understand the world we live in for both scientists and society. To do so, the Biotech community, policymakers, companies and academia are invited to organise their own events on the local level addressing the benefits of biotech for people and the planet.

‘We are delighted to host European Biotech Week in its 9th edition. Previous years have proved that public information is crucial for informed European citizens on biotechnology and its impact on their health and everyday life. At the same time, this week is a perfect opportunity for scientists, companies, academia and policymakers to gather together physically or online and address ongoing challenges and find synergies for enhanced collaboration, says Dr Claire Skentelbery, Director General of EuropaBio.

This year’s Biotech Week will be launched with EuropaBio event ‘Biotechnology for society - Turning science into a sustainable and healthy world’ which will take place on the 27th of September. The biotech community will discuss how science finds its way to an end-use, whether it is a new medicine, or a product developed using new scientific processes.

On the 29th of September EuropaBio’s Healthcare team will host the event ‘Investing in healthcare - How can the revision of the general pharmaceutical legislation better attract investors in the future?’. The event will look into the evaluation and revision of the general pharmaceutical legislation and how to create a future-proof, patient-oriented and leading life science and biotechnology sector in the EU.

Finally, the Association’s Industrial team will discuss the potential of SMEs in the discussion organised on the 30th of September. The event, titled ‘The small companies changing the world: Meet the science and business of sustainability’ will celebrate progress towards a more sustainable and climate-neutral life, and learn from the best solutions from European SMEs.

If you want to host the event as a part of the European Biotech Week (free of charge) please contact us here.

EuropaBio’s events as a part of the European Biotech week:

• Biotechnology for society - Turning science into a sustainable and healthy world (launch event) 15.30-17.00 CEST September 27, 2021. Online, please register here.

• ‘Investing in healthcare - How can the revision of the general pharmaceutical legislation better attract investors in the future? 14.00-15.30 CEST September 29, 2021. Online, please register here.

• The small companies saving the world: Meet the science and business of sustainability. 14.00-15.00 CEST September 30, 2021. Online, please register here.

European Biotech Week 2021: EuropaBio invites national biotech communities to celebrate science and innovation


Download
Press-release_Biotech-weekDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

07/07/2025

EuropaBio Position on the Critical Medicines Act


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more
26/06/2025

EuropaBio AGM 2025: Association Chair, Executive Committee and Board announced


Read more

Important links

  • EuropaBio Position on the Critical Medicines Act
  • Life Sciences Strategy Embraces Biotech for Global Impact

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.